NCT02078401
Unknown
N/A
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
ConditionsNeurofibromatosis Type 1
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Neurofibromatosis Type 1
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Visual acuity
- Last Updated
- 11 years ago
Overview
Brief Summary
The goal of this project is to get more insight into the (neuro)ophthalmological characteristics of children with neurofibromatosis type 1. This way investigators would like to update the current guidelines for follow up and treatment of optic pathway gliomas. Clinical findings will be compared with the results of Optical coherence tomography (OCT) and MRI (magnetic resonance imaging).
Investigators
Dr. Catherine Cassiman
MD
Universitaire Ziekenhuizen KU Leuven
Eligibility Criteria
Inclusion Criteria
- •neurofibromatosis type 1
Exclusion Criteria
- •no neurofibromatosis type 1
Outcomes
Primary Outcomes
Visual acuity
Time Frame: childhood (0 to 18y)
Presence of optic pathway glioma
Time Frame: childhood (0 to18y)
Study Sites (1)
Loading locations...
Similar Trials
Terminated
N/A
Tissue Studies of Human Eye DiseasesRetinal DiseaseCorneal DiseaseDiabetic RetinopathyUveitisAge-Related Macular DegenerationNCT00001310National Eye Institute (NEI)3,833
Not Yet Recruiting
N/A
Eye-tracking Investigation of Clinical Measures in Multiple SclerosisMultiple SclerosisNCT06283524Innodem Neurosciences100
Unknown
N/A
Analysis of Ocular and Neurodevelopmental Function for Retinopathy of PrematurityRetinopathy of PrematurityNeurodevelopmental AbnormalityNCT05186155Chang Gung Memorial Hospital510
Unknown
N/A
Ultrasonic Evaluation of Ocular TissuesGlaucomaTumorsAge-Related Macular DegenerationNCT00279695Weill Medical College of Cornell University150
Completed
Phase 4
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With GlaucomaOcular HypertensionOpen-Angle GlaucomaNCT01369771FinnMedi Oy30